Bank Pictet & Cie Europe AG raised its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 5.2% in the third quarter, HoldingsChannel.com reports. The firm owned 374,472 shares of the conglomerate’s stock after purchasing an additional 18,376 shares during the quarter. Danaher accounts for approximately 1.6% of Bank Pictet & Cie Europe AG’s portfolio, making the stock its 17th biggest holding. Bank Pictet & Cie Europe AG’s holdings in Danaher were worth $82,964,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in DHR. BlackRock Inc. bought a new stake in shares of Danaher in the 2nd quarter valued at $10,492,520,000. Wellington Management Group LLP raised its stake in Danaher by 10.4% during the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock worth $3,108,031,000 after buying an additional 1,542,310 shares during the last quarter. Jupiter Topco LLC bought a new position in Danaher during the second quarter worth $1,456,317,000. Generation Investment Management LLP acquired a new position in Danaher in the second quarter valued at $1,287,949,000. Finally, Bank of America Corp DE acquired a new position in Danaher in the second quarter valued at $993,846,000. Institutional investors own 79.05% of the company’s stock.
Danaher Stock Up 0.2%
Shares of DHR stock traded up $0.43 on Tuesday, reaching $224.86. 3,822,917 shares of the company were exchanged, compared to its average volume of 4,448,633. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The company has a 50-day moving average of $214.35 and a 200-day moving average of $196.30. The company has a market cap of $158.08 billion, a price-to-earnings ratio of 39.88, a PEG ratio of 2.88 and a beta of 0.76. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same period in the previous year, the company posted $0.77 EPS. The firm’s revenue was up 5.5% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.
Danaher Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is 28.42%.
Wall Street Analysts Forecast Growth
DHR has been the topic of a number of research analyst reports. Barclays upped their price target on shares of Danaher from $230.00 to $255.00 and gave the company an “overweight” rating in a research report on Wednesday, October 7th. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research report on Sunday. Wells Fargo & Company lowered their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. The Goldman Sachs Group boosted their price objective on Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a research note on Monday, September 21st. Finally, TD Cowen upped their target price on Danaher from $236.00 to $255.00 and gave the company a “buy” rating in a research report on Tuesday, October 13th. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $235.41.
Check Out Our Latest Report on DHR
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.
The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.
Read More
- Five stocks we like better than Danaher
- IonQ’s Bold Expansion Could Leave Shareholders Paying the Price
- Powering Up: Applied Digital Execs Buy $6.7M in Stock
- Chip Stocks Are Sliding—Why Is Smart Money Buying?
- Adults Are Fueling a Toy Boom—These 4 Stocks Could Cash In
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
